A month af­ter GSK's win in Zan­tac can­cer case, plain­tiffs file dozens more suits

GSK now has dozens more Zan­tac law­suits to con­tend with.

Plain­tiffs on Wednes­day filed 88 suits against GSK in Delaware court on be­half of more than 7,000 claimants who al­lege the pop­u­lar ran­i­ti­dine heart­burn prod­ucts caused a range of can­cers. Pfiz­er, Boehringer In­gel­heim and Sanofi, which owned Zan­tac rights at var­i­ous points in time, were al­so named in the suit, in ad­di­tion to Ther­mo Fish­er’s Patheon Man­u­fac­tur­ing Ser­vices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER